New Mass Spec Software Simplifies Data Analysis
Shimadzu’s Imagereveal MS mass spectrometry imaging data analysis software can analyze large sets of data or simultaneously analyze multiple sets of data.
The Imagereveal MS mass spectrometry imaging data analysis software from Shimadzu simplifies the data analysis process by enabling data to be analyzed from a variety of perspectives without requiring extra time or effort. The software is suited to analyze large sets of data or simultaneously analyze multiple sets of data.
Mass spectrometry imaging is used to analyze two-dimensional images that show the distribution of substances measured with a mass spectrometer. The company reports that in recent years, technical advancements in spatial resolution and mass accuracy have generated excessively large amounts of data that inhibit data analysis.
The software resolves these issues by offering functionalities that search massive amounts of mass spectrometry imaging data for the information required, which can dramatically improve research efficiency, as stated by the company. The software includes six types of functionality for data analysis with different availabilities of that functionality depending on the license selected by the user. A data converter can also be used to analyze data measured by a mass spectrometer not manufactured by the company.
Shimadzu will exhibit the software at the Japan Analytical Instruments Manufacturers (JASIS) convention, from Sept. 5–7, 2018 at the Makuhari Messe International Exhibition Hall in Chiba, Japan.
Source: Shimadzu
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
July 16th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.
